Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pierre Fabre Limited
Hyde Abbey House, 23 Hyde Street, Winchester, Hampshire, SO23 7DR
Telephone: +44 (0)1962 874 400
Fax: +44 (0)1962 844 014
Medical Information Direct Line: +44 (0)1962 874 435
Medical Information e-mail: medicalinformation@pierre-fabre.co.uk
Customer Care direct line: +44 (0)1962 874 402
Medical Information Fax: +44 (0)1962 874 413

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 12/01/2011
PIL TOPAL chewable tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/01/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Extra statutory information
  • Change to manufacturer contact details
  • Changes to therapeutic indications
Updated on 24/06/2005 and displayed until 12/01/2011
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  alginic acid
  magnesium carbonate
  aluminium hydroxide gel, dried